Prof Mark Smales, a principal investigator at NIBRT, has received more than €3.5m from Research Ireland to advance biotheraupeutics.

Ten projects at Queen’s are receiving support from the Canadian Institutes of Health Research to advance research that will have a high impact on health care knowledge and delivery.